The Making More Health (MMH) accelerator, organised by Ashoka, is currently in its fourth year and aims to unlock the potential for growth, impact, and sustainability of promising startups in the health sector in a bid to advance access to healthcare in targeted countries across Africa.
Since 2011, Ashoka – one of the world’s largest networks of social entrepreneurs and Boehringer Ingelheim – a family-owned world-leading, and research-driven Pharmaceutical company, have collaborated to co-create and grow the global initiative – Making More Health (MMH).
No ad to show here.
A structured business growth programme that provides various benefits including knowledge access, strategic networks, technical expertise and more, the programme consists of two phases.
Phase 1 – the “Pilot Phase” runs for 12 months and involves co-creation and pilot implementation of a high-impact strategic project or initiative to drive growth, impact, and sustainability of participating businesses. The Pilot Phase comes with financial support of Euro 50,000 (R884 895,00).
Phase 2 – the “Scale-up Phase” also runs for 12 months and follows the successful implementation of the pilot phase. Businesses that advance to the scale-up phase receive additional financial support of between Euro 100K-200K (R1 769 790,00 – R3 539 580,00). Co-creation involving hand-in-hand collaboration between the social entrepreneurs and Boehringer Ingelheim employees who volunteer to contribute their time and expertise to the pilot and scale-up projects is a key component of both phases of the program.
Applications for the MMH accelerator close on January 31.
Read more: Applications open for new SaaS-focused accelerator in Africa
Feature image: Supplied
